Disruption of the Pum2 axis Aggravates neuronal damage following cerebral Ischemia-Reperfusion in mice

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Stroke is a major cause of death and disability globally.
• Mitochondrial dysfunction is a key factor in ischemic stroke injury.
• Understanding molecular regulators of mitochondrial function is critical for stroke treatment.

Purpose of the Study:

• To investigate the role of the Norad-Pum2-Mff axis in regulating mitochondrial function after ischemia-reperfusion (I/R) injury.
• To elucidate the molecular mechanisms by which Norad, Pum2, and Mff interact to influence neuronal survival and mitochondrial integrity.
• To evaluate the therapeutic potential of modulating this axis in preclinical models of ischemic stroke.

Main Methods:

• Utilized an in vitro oxygen-glucose deprivation/reoxygenation (OGD/R) model of neuronal injury.
• Employed molecular biology techniques to assess protein and mRNA levels of Mff, Pum2, and Norad.
• Investigated the binding interactions between Norad, Pum2, and Mff mRNA using immunoprecipitation assays.
• Performed in vivo studies using a mouse model of middle cerebral artery occlusion/reperfusion (MCAO/R).
• Assessed mitochondrial morphology, neuronal injury, infarct volume, and neurobehavioral outcomes.

Main Results:

• Mff protein levels increased post-OGD/R, independent of mRNA changes, indicating post-transcriptional regulation.
• Pum2 inhibited Mff translation, while Norad sequestered Pum2, relieving this inhibition.
• OGD/R induced decreased Pum2 and increased Norad levels in neurons, altering their binding interactions.
• Overexpression of Pum2 reduced Mff levels, mitigated mitochondrial fragmentation, and alleviated neuronal injury in vitro.
• In vivo, Pum2 overexpression improved mitochondrial morphology, reduced infarct volume, and enhanced neurobehavioral recovery in MCAO/R mice.

Conclusions:

• The Norad-Pum2-Mff axis is a critical regulator of mitochondrial function and neuronal survival in the context of ischemic stroke.
• Modulating this axis, particularly by increasing Norad or decreasing Pum2 activity, offers a promising therapeutic avenue.
• Targeting the Norad-Pum2-Mff pathway could represent a novel strategy for stroke treatment by restoring mitochondrial homeostasis and protecting against ischemic brain damage.